CD44 and ovarian carcinoma: To identify candidate small molecule compounds that can reverse drug resistance in MDR cell lines, we designed an assay to detect reconstitution of paclitaxel cytotoxicity in a Pgp1-expressing, multidrug resistant human ovarian cancer cell line SKOV-3TR.